会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Dihydropyridine derivatives, process for their preparation, pharmaceutical composition and use
    • 二氢吡啶衍生物,它们的制备方法,药物组合物和用途。
    • EP0265947A2
    • 1988-05-04
    • EP87115905.9
    • 1987-10-29
    • GREEN CROSS CORPORATION
    • Ashimori, AtsuyukiOno, Taizo Haitsu Higashiyama 22Inoue, YoshihisaFukaya, ChikaraYokoyama, Kazumasa
    • C07D211/90C07D401/04C07D401/14C07D417/12C07D417/14A61K31/445
    • C07D401/04C07D401/14C07D417/12C07D417/14
    • Dihydropyridine derivatives represented by formula (I):
      wherein Ri, R 2 , R 3 and R 6 , which may be the same or different, each represents an alkyl group, a cycloalkyl group or an alkoxyalkyl group; R 4 and R 5 , which may be the same or different, each represents a hydrogen atom, a halogen atom, a nitro group, a halogenated alkyl group, an alkylsulfonyl group, a halogenated alkoxy group, an alkylsulfinyl group, an alkyl group, a cycloalkyl group, an alkoxy group, a cyano group, an alkoxycarbonyl group or an alkylthio group (provided that R 4 and R 5 are not hydrogen atoms at the same time); X represents a vinylene group or an azomethine group; A and B are each an alkylene group or an alkenylene group; R 7 and Rs, which may be the same or different, each represents a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group, an aryl group, or a heterocyclic group (provided that R 7 and R 8 may combine with the adjacent nitrogen atom to form a hetero ring), and acid addition salts of the dihydropyridine derivative of formula (I), and use of the same in the preparation of a medicament for the treatment of vascular disorders.
    • 由式(I)表示的二氢吡啶衍生物: worin R1,R2,R3和R6,其可以是相同或不同的,烷基,环烷基或烷氧基,在组中的每个darstellt; R4和R5可以相同或不同,各自darstellt氢原子,卤原子,硝基,卤代烷基,烷基磺酰基在基,卤代烷氧基,以烷基亚磺酰基烷基氧基,环 组,以烷氧基,氰基,烷氧基羰基或在烷基硫基(提供确实R4和R5不同时为氢原子); X表示在甲亚胺基团的亚乙烯基或; A和B各自为亚烷基或亚烯基的; R7和R8,其可以是相同或不同的,各自为芳烷基基团darstellt氢原子,烷基的氮烯基于芳基,或杂环基(条件没有R7和R8可与相邻的结合 原子结合形成杂环),和式(I的二氢吡啶衍生物的酸加成盐),和在制备用于治疗血管疾病的治疗中使用相同的。